Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Boehringer Ingelheim
Cantor Fitzgerald
Farmers Insurance
Healthtrust
Cipla
Johnson and Johnson
Chinese Patent Office
Daiichi Sankyo

Generated: October 20, 2018

DrugPatentWatch Database Preview

Cppi Cv Company Profile

« Back to Dashboard

What is the competitive landscape for CPPI CV, and when can generic versions of CPPI CV drugs launch?

CPPI CV has one approved drug.

There are three US patents protecting CPPI CV drugs.

Summary for Cppi Cv
US Patents:3
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Cppi Cv

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cppi Cv SUTENT sunitinib malate CAPSULE;ORAL 021938-004 Mar 31, 2009 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial
Cppi Cv SUTENT sunitinib malate CAPSULE;ORAL 021938-004 Mar 31, 2009 RX Yes No 6,573,293 ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Cppi Cv SUTENT sunitinib malate CAPSULE;ORAL 021938-002 Jan 26, 2006 RX Yes No 6,573,293 ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Cppi Cv SUTENT sunitinib malate CAPSULE;ORAL 021938-002 Jan 26, 2006 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial
Cppi Cv SUTENT sunitinib malate CAPSULE;ORAL 021938-001 Jan 26, 2006 RX Yes No 7,211,600 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for CPPI CV drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Capsules 12.5 mg, 25 mg, 37.5 mg and 50 mg ➤ Subscribe 2010-01-26

Supplementary Protection Certificates for Cppi Cv Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2 Finland ➤ Try a Free Trial
657 Luxembourg ➤ Try a Free Trial 91657, EXPIRES: 20240923
C/GB08/007 United Kingdom ➤ Try a Free Trial PRODUCT NAME: SUNITINIB, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, INCLUDING THE L- MALATE SALT; REGISTRATION NO/DATE: EU/1/06/347/001 - 003 20060724
2010 00004 Denmark ➤ Try a Free Trial PRODUCT NAME: TOCERANIB, HERUNDER TOCERANIBPHOSPHAT
407 Luxembourg ➤ Try a Free Trial 91407, EXPIRES: 20210719
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Federal Trade Commission
Fish and Richardson
Cerilliant
Medtronic
US Army
Citi
Dow
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.